TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GlaxoSmithKline Pharma A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
844,504
|
706,409
|
658,876 |
| Earnings before taxes |
25,044
|
23,022
|
21,461 |
| Total assets |
152,580
|
174,674
|
173,297 |
| Current assets |
149,468
|
171,123
|
169,183 |
| Current liabilities |
93,871
|
118,264
|
117,694 |
| Equity capital |
58,709
|
56,410
|
55,289 |
| - share capital |
15,397
|
14,888
|
14,965 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.5%
|
32.3%
|
31.9% |
| Turnover per employee |
11,260
|
9,419
|
8,785 |
| Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.3% |
| Return on assets (ROA) | |||
| Current ratio |
159.2%
|
144.7%
|
143.7% |
| Return on equity (ROE) |
42.7%
|
40.8%
|
38.8% |
| Change turnover |
113,930
|
50,909
|
-8,365 |
| Change turnover % |
16%
|
8%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.